Encompass Health Corporation
EHC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $5,373 | $4,801 | $4,349 | $4,015 |
| % Growth | 11.9% | 10.4% | 8.3% | – |
| Cost of Goods Sold | $3,140 | $2,818 | $2,595 | $2,312 |
| Gross Profit | $2,233 | $1,983 | $1,753 | $1,703 |
| % Margin | 41.6% | 41.3% | 40.3% | 42.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $267 | $202 | $209 | $229 |
| SG&A Expenses | $267 | $258 | $209 | $229 |
| Sales & Mktg Exp. | $0 | $56 | $0 | $0 |
| Other Operating Expenses | $1,102 | $0 | $914 | $816 |
| Operating Expenses | $1,369 | $258 | $1,123 | $1,044 |
| Operating Income | $865 | $1,725 | $630 | $659 |
| % Margin | 16.1% | 35.9% | 14.5% | 16.4% |
| Other Income/Exp. Net | -$115 | -$1,118 | -$179 | -$154 |
| Pre-Tax Income | $750 | $607 | $451 | $505 |
| Tax Expense | $150 | $132 | $100 | $102 |
| Net Income | $456 | $352 | $271 | $412 |
| % Margin | 8.5% | 7.3% | 6.2% | 10.3% |
| EPS | 4.53 | 3.54 | 2.72 | 4.15 |
| % Growth | 28% | 30.1% | -34.5% | – |
| EPS Diluted | 4.46 | 3.47 | 2.7 | 4.11 |
| Weighted Avg Shares Out | 100 | 100 | 99 | 99 |
| Weighted Avg Shares Out Dil | 102 | 101 | 100 | 100 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $137 | $144 | $176 | $164 |
| Depreciation & Amortization | $300 | $274 | $244 | $220 |
| EBITDA | $1,187 | $1,006 | $870 | $889 |
| % Margin | 22.1% | 20.9% | 20% | 22.1% |